- Home
- AGAE vs DRRX Comparison
AGAE vs DRRX Comparison
Compare AGAE & DRRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGAE
- DRRX
- Stock Information
- Founded
- AGAE 2017
- DRRX 1998
- Country
- AGAE United States
- DRRX United States
- Employees
- AGAE N/A
- DRRX N/A
- Industry
- AGAE Cable & Other Pay Television Services
- DRRX Biotechnology: Pharmaceutical Preparations
- Sector
- AGAE Telecommunications
- DRRX Health Care
- Exchange
- AGAE Nasdaq
- DRRX Nasdaq
- Market Cap
- AGAE 73.8M
- DRRX 59.3M
- IPO Year
- AGAE N/A
- DRRX 2000
- Fundamental
- Price
- AGAE $1.19
- DRRX $1.90
- Analyst Decision
- AGAE
- DRRX Hold
- Analyst Count
- AGAE 0
- DRRX 1
- Target Price
- AGAE N/A
- DRRX N/A
- AVG Volume (30 Days)
- AGAE 26.5K
- DRRX 3.0M
- Earning Date
- AGAE 08-14-2025
- DRRX 08-12-2025
- Dividend Yield
- AGAE N/A
- DRRX N/A
- EPS Growth
- AGAE N/A
- DRRX N/A
- EPS
- AGAE N/A
- DRRX N/A
- Revenue
- AGAE $8,254,861.00
- DRRX $1,657,000.00
- Revenue This Year
- AGAE N/A
- DRRX N/A
- Revenue Next Year
- AGAE N/A
- DRRX $673.00
- P/E Ratio
- AGAE N/A
- DRRX N/A
- Revenue Growth
- AGAE 0.52
- DRRX N/A
- 52 Week Low
- AGAE $0.70
- DRRX $0.48
- 52 Week High
- AGAE $3.79
- DRRX $2.64
- Technical
- Relative Strength Index (RSI)
- AGAE 25.82
- DRRX 81.58
- Support Level
- AGAE $1.51
- DRRX $1.85
- Resistance Level
- AGAE $1.60
- DRRX $1.92
- Average True Range (ATR)
- AGAE 0.10
- DRRX 0.04
- MACD
- AGAE -0.02
- DRRX -0.02
- Stochastic Oscillator
- AGAE 0.00
- DRRX 80.00
About AGAE Allied Gaming & Entertainment Inc.
Allied Gaming & Entertainment Inc is an experiential entertainment company focused on providing a growing world of gamers with various experiences through renowned assets, products, and services.
About DRRX DURECT Corporation
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories, which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from Europe.